GlassScriptPhysician profile
Gregory W Oldham
NPI 1205065646
$3,213.28
in general payments reported to CMS, 2019-2025
19 companies · $637 in 2025
The $637 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $678 · 2020: $104 · 2021: $193 · 2022: $431 · 2023: $770 · 2024: $401 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,807.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,240.57 | 2019-2025 | Clareon Panoptix Pro, Clareon, Argos |
| Abbvie INC. | $549.35 | 2022-2025 | |
| Allergan, INC. | $280.65 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $227.67 | 2019-2023 | Cequa |
| New World Medical,INC. | $223.31 | 2019-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $153.84 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $76.49 | 2022-2023 | Vyzulta, Miebo |
| Novartis Pharmaceuticals Corporation | $72.22 | 2019 | |
| Aerie Pharmaceuticals, INC. | $59.03 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $55.46 | 2023-2025 | Eylea Hd |
| Glaukos Corporation | $53.87 | 2024-2025 | Idose, Idosetr |
| Rayner Intraocular Lenses Limited | $43.59 | 2023 | Omidria, Rayone Spheric, Rayone Emv |
| Sight Sciences, INC. | $42.74 | 2020 | |
| Thea Pharma INC. | $37.87 | 2023-2025 | Iyuzeh |
| Oyster Point Pharma, INC. | $29.18 | 2023 | Tyrvaya |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omeros Corporation | $19.81 | 2019 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Biotissue Holdings INC. | $16.75 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $13.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Oldham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.